10. Fentora - Top 10 Warnings and Recalls
Drug: Fentora
2006 sales: $370 million
Manufacturer: Cephalon
Safety concern: Warning; improper dosing leading to death
Related Articles:
> New warning for off-label Fentora. Report
> Red flags raised on Fentora misuse. Report
> FDA approves Fentora for cancer pain. Report
> Cephalon shares jump on Fentora decision. Report
> Cephalon takes heat for off-label narcotic promotion. Report
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
SHARE
WITH: